Purple Biotech advances NT219 into Phase II recurrent/metastatic SCCHN study
The study is structured with two single-arm cohorts, each following a Simon 2-stage approach.

The study is structured with two single-arm cohorts, each following a Simon 2-stage approach.
With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic
Respite from rising trial costs is a distant dream in 2025
Insilico announces positive results from Phase I trials of AI-designed ISM5411